Europap Tezol EBITDA vs. Revenue
TEZOL Stock | 14.39 0.06 0.42% |
For Europap Tezol profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Europap Tezol to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Europap Tezol Kagit utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Europap Tezol's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Europap Tezol Kagit over time as well as its relative position and ranking within its peers.
Europap |
Europap Tezol Kagit Revenue vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Europap Tezol's current stock value. Our valuation model uses many indicators to compare Europap Tezol value to that of its competitors to determine the firm's financial worth. Europap Tezol Kagit is currently regarded as top stock in ebitda category among its peers. It also is currently regarded number one company in revenue category among its peers totaling about 2.96 of Revenue per EBITDA. Comparative valuation analysis is a catch-all model that can be used if you cannot value Europap Tezol by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Europap Tezol's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Europap Revenue vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Europap Tezol |
| = | 297.13 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Europap Tezol |
| = | 878.15 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Europap Revenue vs Competition
Europap Tezol Kagit is currently regarded number one company in revenue category among its peers. Market size based on revenue of Paper & Paper Products industry is at this time estimated at about 212.53 Billion. Europap Tezol adds roughly 878.15 Million in revenue claiming only tiny portion of equities listed under Paper & Paper Products industry.
Europap Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Europap Tezol. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Europap Tezol position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Europap Tezol's important profitability drivers and their relationship over time.
EBITDA vs Shares Owned By Insiders | ||
Net Income vs Revenue | ||
EBITDA vs Total Debt | ||
Book Value Per Share vs Revenue | ||
EBITDA vs Cash Flow From Operations | ||
Number Of Employees vs Revenue | ||
EBITDA vs Total Asset |
Use Europap Tezol in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Europap Tezol position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Europap Tezol will appreciate offsetting losses from the drop in the long position's value.Europap Tezol Pair Trading
Europap Tezol Kagit Pair Trading Analysis
The ability to find closely correlated positions to Europap Tezol could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Europap Tezol when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Europap Tezol - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Europap Tezol Kagit to buy it.
The correlation of Europap Tezol is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Europap Tezol moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Europap Tezol Kagit moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Europap Tezol can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Europap Tezol position
In addition to having Europap Tezol in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Pharmaceutical Products Thematic Idea Now
Pharmaceutical Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
View All Next | Launch |
Other Information on Investing in Europap Stock
To fully project Europap Tezol's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Europap Tezol Kagit at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Europap Tezol's income statement, its balance sheet, and the statement of cash flows.